On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...